Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-12-27

FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan Pharmaceuticals' original ANDA for cetirizine hydrochloride, a generic antihistamine used to treat allergic rhinitis and chronic urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

ORIG AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)